优化抗感染治疗减少附加损害幻灯片资料.ppt

文档介绍：优化抗感染治疗减少附加损害
抗菌药物与附加损害的相关性
MRSA
VRE
产ESBLs 菌株
MDR铜绿假单胞菌
MDR不动杆菌
难辨梭状芽孢杆菌
(CDAD)
四代头孢菌素
(头孢吡肟)
碳青霉烯类
(亚***培南/美罗培南)
三代头孢菌素
喹诺***
真菌的定植和感染
ICU部门耐药细菌导致感染1999 versus 1994-98
Organism # Isolates % Increase*
Flu-R Pseudomonas spp. 2657 49%
3rdG-C-R E. coli 1551 48%
MRSA 2546 40%
VRE 4744 40%
IMP-R Pseudomonas spp. 1839 20%
* Percent increase in proportion of pathogens resistant to indicated antimicrobial
Source: National ial Infections Surveillance (NNIS) System
MRSA Among ICU Patients
1995-2004
Source: National ial Infections Surveillance (NNIS) System
VRE Among ICU Patients
1995-2004
Source: National ial Infections Surveillance (NNIS) System
3rd-G RK Among ICU Patients
1995-2004
Source: National ial Infections Surveillance (NNIS) System
FQRP Among ICU Patients
1995-2004
Source: National ial Infections Surveillance (NNIS) System
160万
25万
2/3

10% ID related to Res. Bug